Bayer Aktiengesellschaft (BAYZF)
OTCMKTS · Delayed Price · Currency is USD
31.07
+0.32 (1.04%)
Oct 31, 2025, 4:00 PM EDT
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 91,864 employees as of December 31, 2024. The number of employees decreased by 5,067 or -5.23% compared to the previous year.
Employees
91,864
Change (1Y)
-5,067
Growth (1Y)
-5.23%
Revenue / Employee
$605,506
Profits / Employee
-$44,822
Market Cap
30.54B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Dec 31, 2021 | 95,950 | -5 | -0.01% |
| Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
Bayer Aktiengesellschaft News
- 3 days ago - Bayer's Monsanto must pay $185 million after Washington court restores chemical leak verdict - Yahoo
- 4 days ago - Bayer and Luke Bryan Mark 10 Years of Fighting Hunger with YourUpdateTV - GlobeNewsWire
- 9 days ago - Bayer Wins FDA Approval for Menopause Drug Treating Hot Flashes - Financial Post
- 9 days ago - US FDA approves Bayer's menopause relief drug - Reuters
- 9 days ago - Bayer's Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause - Business Wire
- 12 days ago - Top 3 Health Care Stocks You'll Regret Missing In October - Benzinga
- 13 days ago - Bayer Leverkusen vs PSG: Head-to-head, match preview, predicted lineups and score prediction - Business Upturn
- 24 days ago - BAYRY Begins Phase I Study With KQB548 in KRAS-Mutated Cancers - Nasdaq